Role of nociceptor αCaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats.
about
Animal models of fibromyalgiaCommonalities between pain and memory mechanisms and their meaning for understanding chronic painCaMKIIα may modulate fentanyl-induced hyperalgesia via a CeLC-PAG-RVM-spinal cord descending facilitative pain pathway in ratsLocal translation and retrograde axonal transport of CREB regulates IL-6-induced nociceptive plasticity.A clinically relevant animal model of temporomandibular disorder and irritable bowel syndrome comorbidity.Genomewide analysis of rat periaqueductal gray-dorsal horn reveals time-, region- and frequency-specific mRNA expression changes in response to electroacupuncture stimulationPlasma membrane mechanisms in a preclinical rat model of chronic painAccounting for the delay in the transition from acute to chronic pain: axonal and nuclear mechanismsFXYD2, a γ subunit of Na⁺, K⁺-ATPase, maintains persistent mechanical allodynia induced by inflammation.Nociceptor beta II, delta, and epsilon isoforms of PKC differentially mediate paclitaxel-induced spontaneous and evoked pain.Distinct terminal and cell body mechanisms in the nociceptor mediate hyperalgesic primingSpinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism.Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain statePost-translational modifications of voltage-gated sodium channels in chronic pain syndromesThe pharmacology of nociceptor primingA-kinase anchoring protein 79/150 coordinates metabotropic glutamate receptor sensitization of peripheral sensory neurons.Marked Sexual Dimorphism in the Role of the Ryanodine Receptor in a Model of Pain Chronification in the Rat.Adenosine-A1 receptor agonist induced hyperalgesic priming type II.Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat.Neuronal calcium signaling in chronic pain.Roles of Proton-Sensing Receptors in the Transition from Acute to Chronic Pain.Chronic Daily Headache: Mechanisms and Principles of Management.Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats.SDF1-CXCR4 Signaling Contributes to the Transition from Acute to Chronic Pain State.Protein Kinase Cϵ (PKCϵ) Promotes Synaptogenesis through Membrane Accumulation of the Postsynaptic Density Protein PSD-95Sexual Dimorphism in a Reciprocal Interaction of Ryanodine and IP3 Receptors in the Induction of Hyperalgesic Priming.Gene therapy with HSV encoding p55TNFR gene for HIV neuropathic pain: an evidence-based mini-review.Targeting novel mechanisms of pain in sickle cell disease.CaMKIIα underlies spontaneous and evoked pain behaviors in Berkeley sickle cell transgenic mice.Age-dependent sexual dimorphism in susceptibility to develop chronic pain in the rat.Regulation of Expression of Hyperalgesic Priming by Estrogen Receptor α in the Rat.Translational Control Mechanisms in Persistent Pain.CaMKIIα Mediates the Effect of IL-17 To Promote Ongoing Spontaneous and Evoked Pain in Multiple Sclerosis.Signalling transduction events involved in agonist-induced PGE2/EP4 receptor externalization in cultured rat dorsal root ganglion neurons.Crosstalk from cAMP to ERK1/2 emerges during postnatal maturation of nociceptive neurons and is maintained during aging.RNA-binding proteins as targets for pain therapeutics
P2860
Q26853562-48AFD91A-7AD4-4EAA-B8DB-406A63A3D592Q28083722-9C071E1E-4376-43B8-854A-DF2B324DFF72Q33657990-53523851-74D8-4FA0-91DA-F37AB8C3B731Q33880969-627C9A77-4F45-4289-8DF8-2EEC5C69BBCEQ34152709-17641888-35D9-49F0-B59F-FE1492837BDDQ34404534-89E267A2-7512-45E1-8882-615D501AB782Q34762388-5384ECCE-06D8-4D5F-B3A1-D693CBB11CA0Q34946158-1E8D4B29-079B-400E-B5B3-17321EDD6F71Q35146207-0D006EB6-FAAC-4097-B9C6-475A06EE8BE1Q35187458-142D46A8-797B-4297-AA4F-BCDB7CCB16ABQ35423741-FFDD7A2B-1943-4135-B70B-94E3D3435D3EQ35515503-DD6F7878-E7D9-4820-963E-05675627A93CQ36108394-83DA9C47-37A1-4314-B431-C8FCC2F17C19Q36249467-D018C46A-71B7-4C87-BB8F-0475FDE94D73Q36332325-7E445BF8-5DB2-460F-AD0A-EBE54B7DF45EQ36751451-CCB4D8F3-3BDD-468C-A988-7CB304840F31Q37157308-0856E72A-6EFA-498C-9E26-309C7E01A0C6Q37308329-28ABCE72-B620-4F28-950E-931E3DB390D7Q37704685-A4B77D7B-7CBA-4C47-B64A-967D8070F4ECQ38228215-5830EFAF-FFF1-48DB-B9C9-55B6E9690EBDQ38644749-38B28AA0-FA45-4343-A213-5DDBCAC0AEC4Q38700966-28897829-7B91-41D7-A8BE-E3B77ABEF2D0Q39566397-E3FAAE51-A9ED-4CA9-8A69-A6958E1EC299Q39891334-6399E7B2-74C2-40C9-BFA0-FFDF474E33EBQ42037616-59F92796-9EC3-48A0-A4BE-50ABB3A10A18Q42318088-77E4B1A8-0F20-47D6-AC05-ADDB300A5014Q45874354-2018EAEC-FAEA-4ED8-A30F-7305A45223F3Q46051242-B0D49FCF-C627-4C70-ACDA-DDEDA9DC2679Q46178503-0A4886CA-5309-42A2-9538-50955984A795Q46485544-97A8AA18-08B0-4F69-8907-0AD9C378E27FQ46755470-D7D9CCA0-9628-45DA-A3F8-006E0A720257Q47220043-3DAF5CF6-3198-4CA9-8DDD-44FA5F4A464EQ47394224-CB3D27A1-F663-4A7C-8F5C-CE362B1F55C4Q47555490-51D33D30-4600-49ED-9758-1F0FAFC12F29Q48130269-ABF8245F-5DAD-4EAA-A49B-AC8EA8BDBAF4Q58130362-84E154C4-38FA-4146-B16E-2786A35CC609
P2860
Role of nociceptor αCaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of nociceptor αCaMKII in ...... ming) in male and female rats.
@en
Role of nociceptor αCaMKII in transition from acute to chronic pain
@nl
type
label
Role of nociceptor αCaMKII in ...... ming) in male and female rats.
@en
Role of nociceptor αCaMKII in transition from acute to chronic pain
@nl
prefLabel
Role of nociceptor αCaMKII in ...... ming) in male and female rats.
@en
Role of nociceptor αCaMKII in transition from acute to chronic pain
@nl
P2093
P2860
P1476
Role of nociceptor αCaMKII in ...... ming) in male and female rats.
@en
P2093
Jon D Levine
Luiz F Ferrari
Oliver Bogen
P2860
P304
11002-11011
P356
10.1523/JNEUROSCI.1785-13.2013
P407
P577
2013-07-01T00:00:00Z